[HTML][HTML] LncRNAs in ovarian cancer progression, metastasis, and main pathways: ceRNA and alternative mechanisms
EA Braga, MV Fridman, AA Moscovtsev… - International journal of …, 2020 - mdpi.com
Ovarian cancer (OvCa) develops asymptomatically until it reaches the advanced stages with
metastasis, chemoresistance, and poor prognosis. Our review focuses on the analysis of …
metastasis, chemoresistance, and poor prognosis. Our review focuses on the analysis of …
[HTML][HTML] Exosomes and exosomal RNAs in breast cancer: A status update
Improved treatment of breast cancer, the world's second most common cancer, requires
identification of new sensitive prognostic and diagnostic biomarkers. Exosomes are lipid …
identification of new sensitive prognostic and diagnostic biomarkers. Exosomes are lipid …
Dual relationship between long non-coding RNAs and STAT3 signaling in different cancers: New insight to proliferation and metastasis
M Ashrafizadeh, MH Gholami, S Mirzaei, A Zabolian… - Life sciences, 2021 - Elsevier
Uncontrolled growth and metastasis of cancer cells is an increasing challenge for
overcoming cancer, and improving survival of patients. Complicated signaling networks …
overcoming cancer, and improving survival of patients. Complicated signaling networks …
[HTML][HTML] Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity
R Zhang, J Tu, S Liu - Seminars in cancer biology, 2022 - Elsevier
Tumors consist of heterogeneous cell populations, and tumor heterogeneity plays key roles
in regulating tumorigenesis, metastasis, recurrence and resistance to anti-tumor therapies …
in regulating tumorigenesis, metastasis, recurrence and resistance to anti-tumor therapies …
Unlocking exosome-based theragnostic signatures: deciphering secrets of ovarian cancer metastasis
Ovarian cancer (OC) is a common gynecological cancer worldwide. Unfortunately, the lack
of early detection methods translates into a substantial cohort of women grappling with the …
of early detection methods translates into a substantial cohort of women grappling with the …
[HTML][HTML] tRNAGlyGCC-Derived Internal Fragment (i-tRF-GlyGCC) in Ovarian Cancer Treatment Outcome and Progression
K Panoutsopoulou, T Dreyer, J Dorn, E Obermayr… - Cancers, 2021 - mdpi.com
Simple Summary In the precision medicine era, epithelial ovarian cancer (EOC) is
characterized by a high death-to-incidence rate and poor 5-year survival. The identification …
characterized by a high death-to-incidence rate and poor 5-year survival. The identification …
Long noncoding RNA WDFY3‐AS2 suppresses tumor progression by acting as a competing endogenous RNA of microRNA‐18a in ovarian cancer
W Li, S Ma, X Bai, W Pan, L Ai… - Journal of cellular …, 2020 - Wiley Online Library
Ovarian cancer (OC) is a fatal cancer in women, mainly due to its aggressive nature and
poor survival rate. The lncRNA‐miRNA‐mRNA (long noncoding RNA‐microRNA …
poor survival rate. The lncRNA‐miRNA‐mRNA (long noncoding RNA‐microRNA …
[HTML][HTML] LncRNA WDFY3-AS2 promotes cisplatin resistance and the cancer stem cell in ovarian cancer by regulating hsa-miR-139-5p/SDC4 axis
Y Wu, T Wang, L Xia, M Zhang - Cancer Cell International, 2021 - Springer
Background Ovarian cancer (OC) is a high-mortality gynecological cancer that is typically
treated with cisplatin, although such treatment often results in chemoresistance. Ovarian …
treated with cisplatin, although such treatment often results in chemoresistance. Ovarian …
Computational approaches in cancer multidrug resistance research: Identification of potential biomarkers, drug targets and drug-target interactions
Like physics in the 19th century, biology and molecular biology in particular, has been
fertilized and enhanced like few other scientific fields, by the incorporation of mathematical …
fertilized and enhanced like few other scientific fields, by the incorporation of mathematical …
[HTML][HTML] Long noncoding RNA HOST2, working as a competitive endogenous RNA, promotes STAT3-mediated cell proliferation and migration via decoying of let-7b in …
K Hua, X Deng, J Hu, C Ji, Y Yu, J Li, X Wang… - Journal of Experimental …, 2020 - Springer
Background Human ovarian cancer specific transcript 2 (HOST2) is a long non-coding RNA
(lncRNA) reported to be specifically high expressed in human ovarian cancer. However, the …
(lncRNA) reported to be specifically high expressed in human ovarian cancer. However, the …